Head Global Clinical Development (PSS07798)

About the Company

One of India’s 4th largest pharmaceutical companies, headquartered in Delhi, is expanding its innovative medicines portfolio across biologics and small-molecule programs. The organization is in a dynamic growth phase, building a global presence with a mission to deliver transformative therapies to patients worldwide.

Position Overview

The Global Head of Clinical Development will lead the clinical strategy and execution for innovation-driven assets across biologics and small molecules. Reporting to senior R&D leadership, this executive will define and drive global clinical development strategies, working cross-functionally with preclinical, translational, regulatory, commercial, and business development teams to translate scientific innovation into differentiated medicines across multiple geographies.

Key Responsibilities

Set and execute the global clinical development strategy for biologic and small-molecule innovation lead assets, ensuring alignment with scientific, regulatory, and commercial objectives.
Build and lead development teams, including clinical operations, through all phases of development (Phase I–III).
Integrate translational science, biomarkers, and patient-centric endpoints into clinical strategies.
Engage with external stakeholders and KOLs to design cost-effective programs for global health, women’s health, and metabolic disorders portfolios.
Develop and manage external partnerships with organizations such as Gates, Wellcome, and other funding agencies to mobilize collaborative development and funding opportunities.
Collaborate with global regulatory agencies (FDA, EMA, CDSCO) to define clinical pathways and ensure compliant, efficient program execution.
Oversee global clinical execution, partnering with global CROs to ensure data integrity, scientific rigor, and timely delivery.
Work closely with commercial, medical affairs, and market access teams to ensure clinical data supports value demonstration and global launch readiness.
Represent the clinical perspective in business development and partnership evaluations, supporting in-licensing and co-development opportunities.
Establish and lead KOL advisory boards to refine strategy based on evolving science and unmet clinical needs.

Required Experience & Qualifications

Education: MD or PhD in biological or pharmaceutical sciences.
Experience: 10+ years in global clinical development (biologics and/or small molecules) within leading pharma, biotech, or clinical development organizations.
Leadership: Proven success leading end-to-end clinical programs from early phase (Phase I) through Phase III and preferably to registration and launch in the US or Europe.
Technical Expertise: Deep understanding of regulatory pathways (FDA, EMA, CDSCO), translational science, biomarkers, and patient-centric endpoints.
Soft Skills: Strategic thinker with the ability to integrate scientific innovation, operational pragmatism, and commercial insight; global mindset with willingness to travel internationally and collaborate with India-based R&D teams.

Why Consider this Opportunity?

Shape the future of innovation within one of India’s fastest-growing global pharmaceutical organizations.
Lead global clinical development across biologics and small molecules with direct impact on breakthrough therapies.
Drive science from bench to bedside, broadening patient access worldwide.
Collaborate with world-class partners and funding agencies to expand global health impact.
Hold a high-visibility leadership role influencing global R&D strategy and execution.